Skip to content
777 Sourcing.

Capability

pharmacotherapy development

Suppliers
1
States & provinces
1
Countries
1

1 pharmacotherapy development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Amygdala Neurosciences is a biopharmaceutical company headquartered in San Francisco, CA, founded in 2015. Its mission is to address the unmet need associated with alcohol use disorder (AUD) and other substance use disorders (SUD) by discovering, developing, and commercializing safe and effective pharmacotherapies to treat addiction. The company was formed based on technology targeting the enzyme aldehyde dehydrogenase type 2 (ALDH2), acquired from Gilead Sciences.

drug discoverypreclinical development

Related capabilities

Other processes offered by the shops that list pharmacotherapy development.

Browse all capabilities